Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIC Esophageal Cancer AJCC v7”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Large-scale testing (Phase 3)Study completedNCT01107639
What this trial is testing

Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer
Swiss Cancer Institute 297
Testing effectiveness (Phase 2)Study completedNCT00938470
What this trial is testing

Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 73
Early research (Phase 1)Ended earlyNCT01705340
What this trial is testing

Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionHER2-positive Breast CancerMale Breast Cancer+9 more
National Cancer Institute (NCI) 60
Very early researchWithdrawnNCT02857218
What this trial is testing

Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer

Who this might be right for
Stage IIB Esophageal Cancer AJCC v7Stage III Esophageal Cancer AJCC v7Stage IIIA Esophageal Cancer AJCC v7+2 more
OHSU Knight Cancer Institute
Not applicableUnknownNCT00766480
What this trial is testing

Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus

Who this might be right for
Esophageal Cancer
University of Toyama 160
Testing effectiveness (Phase 2)WithdrawnNCT02344810
What this trial is testing

C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more
Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT02389751
What this trial is testing

Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer

Who this might be right for
Gastroesophageal Junction AdenocarcinomaMalignant Neoplasm of the Cervical EsophagusMalignant Neoplasm of the Thoracic Esophagus+5 more
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)WithdrawnNCT03220009
What this trial is testing

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Who this might be right for
Cervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more
National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT02381561
What this trial is testing

Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy

Who this might be right for
Advanced Bile Duct CarcinomaStage II Esophageal Cancer AJCC v7Stage II Pancreatic Cancer AJCC v6 and v7+38 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)UnknownNCT00659113
What this trial is testing

S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery

Who this might be right for
Esophageal Cancer
Yonsei University 32
Large-scale testing (Phase 3)Study completedNCT00655876
What this trial is testing

Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Radiation Therapy Oncology Group 344
Testing effectiveness (Phase 2)Study completedNCT01333033
What this trial is testing

PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer
Alliance for Clinical Trials in Oncology 257
Large-scale testing (Phase 3)Study completedNCT00861094
What this trial is testing

Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer

Who this might be right for
Esophageal Cancer
UNICANCER 266
Testing effectiveness (Phase 2)Study completedNCT00702884
What this trial is testing

Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Tony Bekaii-Saab 25
Large-scale testing (Phase 3)Study completedNCT01243398
What this trial is testing

Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer
University of Oxford 450
Large-scale testing (Phase 3)UnknownNCT00509561
What this trial is testing

Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Wales Cancer Trials Unit 259
Testing effectiveness (Phase 2)Study completedNCT01498289
What this trial is testing

S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric Cancer
SWOG Cancer Research Network 213
Large-scale testing (Phase 3)Study completedNCT00978549
What this trial is testing

Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric Cancer+2 more
Cambridge University Hospitals NHS Foundation Trust 320
Testing effectiveness (Phase 2)Study completedNCT00544362
What this trial is testing

Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery

Who this might be right for
Esophageal Cancer
Federation Francophone de Cancerologie Digestive 33
Load More Results